for High Dimensional Prediction & Behavioral Phenotyping Isaac - - PowerPoint PPT Presentation

for high dimensional prediction
SMART_READER_LITE
LIVE PREVIEW

for High Dimensional Prediction & Behavioral Phenotyping Isaac - - PowerPoint PPT Presentation

Machine Learning: A Framework for High Dimensional Prediction & Behavioral Phenotyping Isaac R. Galatzer-Levy, PhD Mindstrong Health NYU School of Medicine Disclosure Equity and salary from Mindstrong Health 1. Personalized medicine


slide-1
SLIDE 1

Machine Learning: A Framework for High Dimensional Prediction & Behavioral Phenotyping

Isaac R. Galatzer-Levy, PhD Mindstrong Health NYU School of Medicine

slide-2
SLIDE 2

Disclosure

  • Equity and salary from Mindstrong Health
slide-3
SLIDE 3
  • 1. Personalized medicine problem
  • Differential response to treatment
  • Variable & multidetermined treatment effect
  • Strong effects in subpopulations are washed out by averaging across responders and

non-responders

  • The ability to predict responders to Tx [x1…xn] can solve this problem
slide-4
SLIDE 4
  • 2. Phenotyping problem
  • Current clinical definitions
  • Heuristic
  • Heterogeneous
  • Distant from the behavioral and biological phenotypes used in basic and

translational models

  • Good treatments are lost in translation
slide-5
SLIDE 5

Personalized medicine problem

1. 2. 3.

Breast cancer tissues Normal tissues

slide-6
SLIDE 6

Basic principles of classification

6

  • Want to classify objects as boats and houses.
slide-7
SLIDE 7

Basic principles of classification

7

  • All objects before the coast line are boats and all objects after the

coast line are houses.

  • Coast line serves as a decision surface that separates two classes.
slide-8
SLIDE 8

Basic principles of classification

8

These boats will be misclassified as houses

slide-9
SLIDE 9

Basic principles of classification

9

This house will be misclassified as a boat

slide-10
SLIDE 10

High Dimensional Classification

slide-11
SLIDE 11
slide-12
SLIDE 12
slide-13
SLIDE 13
slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16

Neural Networks for Deep Learning

slide-17
SLIDE 17

Hot Dog Not Hot Dog

slide-18
SLIDE 18

Phenotyping problem

  • Need for new ways to define clinical populations that move away

from heuristic description of mental health towards direct behavioral and biological phenotyping

  • Problem
  • High dimensional data
  • No clear clinical interpretation
slide-19
SLIDE 19

Diagnostic Status

2 4 6 8 PTSD + PTSD - 2 4 6 8 PTSD + PTSD -

DSM-IV DSM 5 n= 79,794 6-17 symptoms n=636,120 6-20 symptoms

slide-20
SLIDE 20

Digital Phenotyping

slide-21
SLIDE 21

p n X= Orthogonal Basis

slide-22
SLIDE 22

Now what?

slide-23
SLIDE 23
slide-24
SLIDE 24

Thank You

slide-25
SLIDE 25

Latent Growth Mixture Modeling

T1 T2 T3 T4 S I Q C

slide-26
SLIDE 26

Now what?

slide-27
SLIDE 27
  • I,S,Q=>C

Resilience Chronic Recovery

Time

Latent Growth Mixture Modeling

slide-28
SLIDE 28

Freezing

slide-29
SLIDE 29

Freezing

slide-30
SLIDE 30

Role of FKBP5 on Patterns of Fear Potentiated Startle During Extinction

  • Combined Iraq and Afghan War Vets and Grady ER Sample

n= 721

High FPS Extinguishers: RS1360780 TT=33.33% Model Responders: RS1360780 TT=10.87%

{

Wald (1, 97) = 3.70, p<=.05 High FPS Extinguishers: RS1360780 TT=50.00% Model Responders: RS1360780 TT=16.30%

{

Wald (1, 97) = 3.67, p<=.05

In tru s io n s A v o id a n c e /N u m b in g H y p e ra ro u s a l 1 0 2 0 3 0 P T S D S y m p to m C lu s te rs F e a r P o te n tia te d S ta rtle M o d a l F P S E xtin g u ish e rs H ig h F P S E x tin g u ish e rs H ig h F P S N o n -E x tin g u is h e rs *
slide-31
SLIDE 31

HPA-Axis Augmentation of Extinction and Recall

Galatzer-levy, et. al. (In Press); Neuropharmacology

n= 127

P
  • s
t
  • E
x t i n c t i
  • n
P
  • s
t
  • R
e c a l l 1 2 3 4 A m y g d a la fk b p 5 m R N A H ig h D o se D e x E x tin g u is h e rs N o n -H ig h D o se D e x N o n -E x tin g u ish e rs N o n -H ig h D o se D e x E x tin g u is h e rs * * * * * * * * *
slide-32
SLIDE 32

Problems in Clinical Trial Research

  • Variable & multidetermined treatment effects
  • Personalized medicine problem
  • Heuristic based clinical constructs
  • Behavioral phenotyping problem